Pfizer, BioNTech hit pause on COVID shot trial as enrollment falls flat

Pfizer Inc PFE and its German COVID-19 vaccine partner BioNTech SE BNTX have reportedly halted recruitment for a large U.S.

Exclusive - Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...
kjrh.com

FDA approves Pfizer, Moderna COVID-19 vaccine booster shots to all US adults

WASHINGTON — Pfizer and Moderna say the Food and Drug Administration have opened up COVID-19 booster shots to all adults, letting them choose another dose of either vaccine. The move expands the ...
NBC Los Angeles

Novavax updated Covid vaccine wins FDA, CDC backing, paving way to reach Americans within days

The Food and Drug Administration authorized Novavax's single-strain vaccine, which targets omicron subvariant XBB.1.5, for emergency use in people ages 12 and up. The Centers for Disease Control and ...
Daily Sabah

Pfizer, BioNTech halt US trial of COVID-19 vaccine over low enrollment

Pfizer and BioNTech have halted a major U.S. clinical trial of their updated COVID-19 vaccine in adults aged 50 to 64, citing insufficient ...
ABC7

Pfizer and Moderna COVID-19 vaccines may offer protection for years, new research reveals

New research shows promising signs that the Pfizer and Moderna vaccines might offer protection for a longer time than previously thought. And that protection could potentially last for years Health ...